MedTrace Logo

PAVmed CarpX Device Clinical Study

NCT03747510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-05-01

No results posted yet for this study

Summary

To study the safety and feasibility of the CarpX device to divide and release the transverse carpal ligament in order to provide relief for Carpal Tunnel Syndrome (CTS).

Conditions

  • Carpal Tunnel Syndrome

Interventions

DEVICE

CarpX Device

Transverse carpal ligament release with CarpX Device

Sponsors & Collaborators

  • PAVmed Inc.

    lead INDUSTRY

Principal Investigators

  • Terrence Creagh, MD · Creagh & Associates

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-05
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03747510 on ClinicalTrials.gov